These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Assessment of tumor radioresponsiveness and metastatic potential by dynamic contrast-enhanced magnetic resonance imaging. Øvrebø KM; Gulliksrud K; Mathiesen B; Rofstad EK Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):255-61. PubMed ID: 21816291 [TBL] [Abstract][Full Text] [Related]
5. Dynamic contrast-enhanced magnetic resonance imaging of the metastatic potential of melanoma xenografts. Ovrebø KM; Ellingsen C; Galappathi K; Rofstad EK Int J Radiat Oncol Biol Phys; 2012 May; 83(1):e121-7. PubMed ID: 22381901 [TBL] [Abstract][Full Text] [Related]
6. Assessment of extravascular extracellular space fraction in human melanoma xenografts by DCE-MRI and kinetic modeling. Benjaminsen IC; Brurberg KG; Ruud EB; Rofstad EK Magn Reson Imaging; 2008 Feb; 26(2):160-70. PubMed ID: 17692490 [TBL] [Abstract][Full Text] [Related]
7. Peripheral washout phenomenon in an animal tumour model: comparison of dynamic magnetic resonance imaging using a small molecular contrast medium with histology. Drees R; Hünigen H; Wagner S; Schnorr J; Plendl J; Taupitz M Vet Comp Oncol; 2008 Sep; 6(3):151-61. PubMed ID: 19178675 [TBL] [Abstract][Full Text] [Related]
8. Magnetic resonance imaging enhancement of normal tissues and tumors using macromolecular Gd-based cascade polymer contrast agents: preclinical evaluations. Raatschen HJ; Fu Y; Shames DM; Wendland MF; Brasch RC Invest Radiol; 2006 Dec; 41(12):860-7. PubMed ID: 17099424 [TBL] [Abstract][Full Text] [Related]
9. Comparison of tumor histology to dynamic contrast enhanced magnetic resonance imaging-based physiological estimates. Aref M; Chaudhari AR; Bailey KL; Aref S; Wiener EC Magn Reson Imaging; 2008 Nov; 26(9):1279-93. PubMed ID: 18487033 [TBL] [Abstract][Full Text] [Related]
10. Angiogenesis and fibroblast proliferation precede formation of recurrent tumors after radiation therapy in nude mice. Hast J; Schiffer IB; Neugebauer B; Teichman E; Schreiber W; Brieger J; Kim DW; Gebhard S; Born CJ; Strugala M; Sagemüller J; Brenner W; Mann WJ; Oesch F; Thelen M; Hengstler JG Anticancer Res; 2002; 22(2A):677-88. PubMed ID: 12014637 [TBL] [Abstract][Full Text] [Related]
11. Comparison of tumor blood perfusion assessed by dynamic contrast-enhanced MRI with tumor blood supply assessed by invasive imaging. Graff BA; Benjaminsen IC; Brurberg KG; Ruud EB; Rofstad EK J Magn Reson Imaging; 2005 Mar; 21(3):272-81. PubMed ID: 15723369 [TBL] [Abstract][Full Text] [Related]
12. Dynamic contrast-enhanced magnetic resonance imaging of human melanoma xenografts with necrotic regions. Gaustad JV; Benjaminsen IC; Ruud EB; Rofstad EK J Magn Reson Imaging; 2007 Jul; 26(1):133-43. PubMed ID: 17659570 [TBL] [Abstract][Full Text] [Related]
13. Pathological animal models in the experimental evaluation of tumour microvasculature with magnetic resonance imaging. Faccioli N; Marzola P; Boschi F; Sbarbati A; D'Onofrio M; Pozzi Mucelli R Radiol Med; 2007 Apr; 112(3):319-28. PubMed ID: 17440699 [TBL] [Abstract][Full Text] [Related]
14. Correlation of dynamic contrast-enhanced MR imaging with histologic tumor grade: comparison of macromolecular and small-molecular contrast media. Daldrup H; Shames DM; Wendland M; Okuhata Y; Link TM; Rosenau W; Lu Y; Brasch RC AJR Am J Roentgenol; 1998 Oct; 171(4):941-9. PubMed ID: 9762973 [TBL] [Abstract][Full Text] [Related]
15. Intratumor heterogeneity in blood perfusion in orthotopic human melanoma xenografts assessed by dynamic contrast-enhanced magnetic resonance imaging. Gaustad JV; Benjaminsen IC; Graff BA; Brurberg KG; Ruud EB; Rofstad EK J Magn Reson Imaging; 2005 Jun; 21(6):792-800. PubMed ID: 15906326 [TBL] [Abstract][Full Text] [Related]
16. Solitary pulmonary nodules: association between signal characteristics in dynamic contrast enhanced MRI and tumor angiogenesis. Schaefer JF; Schneider V; Vollmar J; Wehrmann M; Aebert H; Friedel G; Vonthein R; Schick F; Claussen CD Lung Cancer; 2006 Jul; 53(1):39-49. PubMed ID: 16690161 [TBL] [Abstract][Full Text] [Related]
17. Dynamic contrast-enhanced magnetic resonance imaging of tumor interstitial fluid pressure. Gulliksrud K; Brurberg KG; Rofstad EK Radiother Oncol; 2009 Apr; 91(1):107-13. PubMed ID: 18973959 [TBL] [Abstract][Full Text] [Related]
18. Assessment of hypoxia in human cervical carcinoma xenografts by dynamic contrast-enhanced magnetic resonance imaging. Ellingsen C; Egeland TA; Gulliksrud K; Gaustad JV; Mathiesen B; Rofstad EK Int J Radiat Oncol Biol Phys; 2009 Mar; 73(3):838-45. PubMed ID: 19215820 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of Gd(III)DTPA-terminated poly(propylene imine) dendrimers as contrast agents for MR imaging. Langereis S; de Lussanet QG; van Genderen MH; Meijer EW; Beets-Tan RG; Griffioen AW; van Engelshoven JM; Backes WH NMR Biomed; 2006 Feb; 19(1):133-41. PubMed ID: 16450331 [TBL] [Abstract][Full Text] [Related]
20. AG-013736, a novel inhibitor of VEGF receptor tyrosine kinases, inhibits breast cancer growth and decreases vascular permeability as detected by dynamic contrast-enhanced magnetic resonance imaging. Wilmes LJ; Pallavicini MG; Fleming LM; Gibbs J; Wang D; Li KL; Partridge SC; Henry RG; Shalinsky DR; Hu-Lowe D; Park JW; McShane TM; Lu Y; Brasch RC; Hylton NM Magn Reson Imaging; 2007 Apr; 25(3):319-27. PubMed ID: 17371720 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]